Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Rosuvastatin for Preventing Myocardial Damage in Patients With Acute Coronary Syndrome

NCT01245803 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT01245803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01245803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Rosuvastatin for Preventing Myocardial Damage in Patients With Acute Coronary Syndrome
Lead sponsor
Beijing Anzhen Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2010
Completion date
May 31, 2011
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, angioplasty